pancreat
cell
pten
lung
prostat
genet
tumor
metabol
egfr
kinas
mutat
brca2
melanoma
inhibitor
p53
kras
erbb3
protein
cyclin
pharmacolog
drug
breast
met
express
gene
receptor
pik3ca
cancer
resist
gist
pi3k
growth
pdac
adenocarcinoma
erbb2
alk
kit
meningioma
tumour
line
activ
nras
ckit
gastric
gastrointestin
loss
ductal
fusion
amplif
stromal
p16
braf
crizotinib
nsclc
patient
colorect
carcinoma
her2
exon
colon
therapi
fgfr1
nonsmallcel
imatinib
famili
brca1
methyl
surviv
v600e
crc
stomach
brafv600
ovarian
target
thyroid
squamous
epiderm
cholangiocarcinoma
ci
risk
case
eml4alk
cdkn2a
neoplasm
95
codon
factor
os
delet
therapeut
trastuzumab
chemotherapi
germlin
administr
neu
gefitinib
dosag
rearrang
prognost
recurr